Three more biotechs hit Nasdaq as the sector, now with more than $13B raised, continues...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Sep 15, 2021 at 11:12 AM.

  1. #1 cafead, Sep 15, 2021 at 11:12 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via After a summer slumber, the biotech IPO market is back in full swing with three new pricings dropping Wednesday and two SPACs entering the ring.

    DiCE Therapeutics and Tyra Biosciences each hit Nasdaq on Wednesday with nine-figure raises, while small-cap Pasithea Therapeutics also debuted with a $24 million raise. The pricings have pushed the combined industry raise north of $13 billion so far in 2021, per the Endpoints News tracker, a figure likely to eclipse last year’s record total of $16.5 billion.

    article source
     
    Quote

Reply to Thread